Ongentys 50mg (Opicapone Capsule) 50mg

Ongentys 50mg capsules contain opicapone, a prescription medication used alongside levodopa-based therapies to manage Parkinson’s disease motor fluctuations. This non-dopaminergic adjunct helps extend the effects of levodopa by inhibiting catechol-O-methyltransferase (COMT). Store at room temperature away from moisture.

Strength

50mg

Pack Size

30s

Storage

Ambient

Manufacturer / TM Owner

Bial SA Switzerland

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Opicapone 50mg capsules are indicated for adults with Parkinson’s disease experiencing end-of-dose motor fluctuations while on levodopa/dopa-decarboxylase inhibitor therapy. It helps reduce off-time by prolonging the duration of levodopa’s clinical effect. Patients often ask what opicapone 50mg is used for; it is not a standalone treatment but works with existing levodopa regimens to smooth symptom control.

Side Effects

Users may notice improved mobility and reduced wearing-off periods between levodopa doses when taking opicapone 50mg. Some report more consistent symptom control throughout the day, though individual responses vary. It does not replace levodopa but aims to optimize its performance. Common effects include smoother transitions between on and off states.

Precautions & Warnings

Keep opicapone 50mg capsules in their original blister pack until use to protect from moisture. Store at room temperature and avoid exposure to heat or direct sunlight. Always follow your healthcare provider’s instructions for use and monitoring. Report any unusual symptoms to a medical professional promptly.

Avoid Interactions

Opicapone may interact with medications that affect liver enzymes, such as certain antidepressants or antibiotics. Alcohol and high-fat meals can influence absorption, so timing and diet should be consistent. Discuss all current medications with your doctor before starting opicapone 50mg. Monitor for changes in levodopa effects when combined with this therapy.

Frequently Asked Questions

Ongentys 50mg capsules are used with levodopa-based therapies to help manage Parkinson’s disease motor fluctuations.

Store Ongentys 50mg at room temperature in the original blister pack to protect from moisture.

Alcohol may affect how opicapone works; consult your healthcare provider before combining them.

Some users report dizziness or nausea; report persistent effects to your doctor.

No, it is used alongside levodopa therapy to enhance its effectiveness.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.